Six months hormone therapy in addition to radiotherapy improves prostate cancer survival (Medical Xpress, 7 April 2014)

A French study presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna assessed prostate cancer survival rates for men undergoing radiotherapy combined with androgen deprivation therapy. Full article
Source: Society for Endocrinology - Category: Endocrinology Source Type: news